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Preface
An agreement has been signed by the Dutch Expert Committee on Occupational Standards
(DECOS) of the Dutch Health Council and the Swedish Criteria Group for Occupational
Standards (SCG) of the Swedish National Institute for Working Life. The purpose of the
agreement is to write joint scientific criteria documents for occupational exposure limits.
The numerical limits will be developed separately by The Netherlands and Sweden
according to their different national policies.
The evaluation of health effcts of Lactates is a product of this agreement. The draft
document was written by Dr Per Lundberg at the Department of Occupational Medicine,
National Institute for Working Life, Solna, Sweden. The document has been reviewed by
the Dutch Expert Committee as well as by the Swedish Criteria Group.
Gerard Mulder Johan Högberg
Chairman Chairman
DECOS SCG
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11. Introduction
Lactate esters (esters of lactic acid) are used as food additives, in pharmaceuticals
and cosmetics and are currently finding new uses as solvents. Some esters have
been used for many years as solvents for nitro and ethyl cellulose, gums, oils, dyes
and in paints. The esters are potentially alternative solvents to glycol ethers and are
non-ozone-depleting and biodegradable.
The main information on the toxicity of lactate esters has been presented in two
recent reviews (9, 10).
2. Chemical Identification
Two enantiomeric isomers (mirror images) of lactate esters exist, the D- and the L-form.
Often the two isomers are mixed to give the so called DL-form.
Table 1. Name, CAS number, formula and molecular weight for some lactate esters
Lactate CAS nr Formula MW
Methyl 547-64-8 (27871-49-4) C4H8O3 104.1
Ethyl 97-64-3 (687-47-8) C5H10O3 118.1
Isopropyl 617-51-6 (63697-00-7) C6H12O3 132.2
Propyl 616-09-1 (53651-69-7) C6H12O3 132.2
sec-Butyl 18449-60-0 C7H14O3 146.2
Isobutyl 585-24-0 (702-84-0) C7H14O3 146.2
n-Butyl 138-22-7 (34451-19-9) C7H14O3 146.2
Isoamyl 19329-89-6 C8H16O3 160.2
Amyl 6382-06-5 C8H16O3 160.2
2-Ethylhexyl 6283-86-9 (186817-80-1) C11H22O3 202.3
n-Octyl 5464-71-1 (5110-33-4) C11H22O3 202.3
n-Decyl 42175-34-8 (51191-35-6) C13H26O3 230.3
Lauryl 6283-92-7 C15H30O3 258.4
Myristyl 1323-03-1 C17H34O3 286.5
Cetyl 35274-05-6 C19H38O3 314.5
CAS numbers are for DL-forms of the esters. CAS number for the L-forms are given within
parenthesis.
3. Physical and Chemical Properties
Physical and chemical properties are given for the main lactate esters for which
effects are discussed in the document. For some other esters data on physical and
chemical properties are given in the Appendix.
2 Methyl lactate
Melting point - 66 ˚C
Boiling point 144 ˚C
Flash point 57 ˚C
Density 1.092 g/ml (20 ˚C)
Vapor pressure 0.34 kPa (20 ˚C); 23 kPa (100˚C)
Saturation vapor concentration 3302 ppm (20˚C)
Partition coefficient (log Poctanol/water) - 0.53
Conversion factor (20 oC; 101.3 kPa) 1 ppm = 4.3 mg/m3
1 mg/m3 = 0.23 ppm
Methyl lactate is a colorless transparent liquid. It is soluble/miscible in water at
room temperature. Methyl lactate is also soluble in alcohol and ether (10).
Ethyl lactate
Melting point - 25 ˚C
Boiling point 153 ˚C
Flash point 61 ˚C
Density 1.033 g/ml (20 ˚C)
Vapor pressure 0.22 kPa (20 ˚C); 17 kPa (100 ˚C)
Partition coefficient (log Poctanol/water) 0.06
Conversion factor (20 oC; 101.3 kPa) 1 ppm = 4.9 mg/m3
1 mg/m3 = 0.20 ppm
Ethyl lactate is at room temperature a colorless liquid with a mild, characteristic
odor. Ethyl lactate is miscible in water, alcohols, ketones , esters, hydrocarbons,
ether and oil (10). The odor threshold is reported to be 0.89 mg/m3 and the odor
nuisance threshold to be 65 mg/m3 (9).
Isopropyl lactate
Boiling point 157 ˚C
Flash point 60 ˚C
Density 0.991 g/ml (20 ˚C)
Vapor pressure 0.17 kPa (20 ˚C); 15 kPa (100 ˚C)
Partition coefficient (log Poctanol/water) 0.39
Conversion factor (20 oC; 101.3 kPa) 1 ppm = 5.5 mg/m3
1 mg/m3 = 0.18 ppm
Isopropyl lactate is soluble in water, alcohol, ether and benzene (10).
3Isobutyl lactate
Boiling point 182 ˚C
Flash point 76 ˚C
Density 0.979 g/ml (20 ˚C)
Vapor pressure 0.05 kPa (20 ˚C)
Partition coefficient (log Poctanol/water) 1.10
Conversion factor (20 oC; 101.3 kPa) 1 ppm = 6.1 mg/m3
1 mg/m3 = 0.165 ppm
Isobutyl lactate is soluble in water; 5.1 g/100 ml at 20 ˚C (9).
n-Butyl lactate
Melting point - 43 ˚C
Boiling point 187 ˚C
Flash point 79 ˚C
Density 0.984 g/ml (20 ˚C)
Vapor pressure 0.03 kPa (20 ˚C); 4.7 kPa (100 ˚C)
Partition coefficient (log Poctanol/water) 1.10
Conversion factor (20 oC; 101.3 kPa) 1 ppm = 6.1 mg/m3
1 mg/m3 = 0.165 ppm
n-Butyl lactate is at room temperature a water-white liquid with a mild odor. It is
miscible with many lacquer solvents, diluents and oils. It is slightly soluble in water
(4.5 g/100 ml), miscible in alcohol and ether, and hydrolyzes in acids and alkalies
to lactic acid and butyl alcohol (10). The odor threshold is 0.095 mg/m3 and the
odor nuisance threshold is 9 mg/m3 (9). In a review (2) the odor threshold for n-
butyl lactate is reported as 7 ppm (42.6 mg/m3) but the actual source or basis is not
cited.
2-Ethylhexyl lactate
Boiling point 246 ˚C
Flash point 113 ˚C
Density 0.940 g/ml (20 ˚C)
Vapor pressure 0.002 kPa (20 ˚C); 0.6 kPa (100 ˚C)
Partition coefficient (log Poctanol/water) 3.17
Conversion factor (20 oC; 101.3 kPa) 1 ppm = 8.4 mg/m3
The solubility of 2-ethylhexyl lactate in water is 30 mg/100 ml (9). The odor
threshold limit is reported as 0.45 mg/m3 and the odor nuisance threshold as
40 mg/m3 (9).
4Myristyl lactate
Density 0.892 - 0.904 (25 ˚C)
Conversion factor (20 oC; 101.3 kPa) 1 ppm = 11.9 mg/m3
1 mg/m3 = 0.08 ppm
Myristyl lactate is a white to yellow liquid or soft solid. Myristyl lactate is soluble in
ethyl alcohol and propylene glycol, dispersible in mineral oil, and insoluble in water
and glycerine (10).
Cetyl lactate
Melting point 23 - 41 ˚C
Boiling point 170 ˚C (at 2.8 10-3 kPa)
Density 0.893 - 0.905 (25 ˚C)
Conversion factor (20 oC; 101.3 kPa) 1 ppm = 13.05 mg/m3
1 mg/m3 = 0.077 ppm
Cetyl lactate is a white to yellow soft waxy solid with a slight, characteristic,
pleasant odor. It is soluble in ethyl alcohol and propylene glycol (10).
4. Occurrence, Production and Use
Methyl lactate is used as a cellulose acetate solvent (22).
Ethyl lactate is both a commercially produced and a naturally existing compound.
Ethyl lactate is used as a solvent for nitrocellulose, cellulose acetate, and many
cellulose ethers and resins. It is also used in lacquers, paints, enamels, varnishes,
stencil sheets, safety glass and flavoring. Ethyl lactate is furthermore used in some
cosmetic formulations in soaps, detergents, creams and lotions with a maximum
concentration of 0.2 % (10). Ethyl lactate is reported to be found in apple, citrus
fruits, pineapple, peas, sauerkraut, vinegar, bread, beer, grape brandy, rum,
whisky, cider, sherry, wine, cocoa, banty beer, plum brandy and pear brandy. It
has been approved by the US FDA for food use (4). According to earlier editions of
Patty's Industrial Hygiene and Toxicology ethyl lactate was used for treatment of
acne but this information has been withdrawn in the most recent edition (6). In
recent years it has been used as degreaser as a substitute for trichloroethylene (8).
In Sweden the yearly import of ethyl lactate is about 23 tonnes in 22 different
products. There is no information on other lactates (personal communication, Ulf
Rick, Swedish Chemicals Inspectorate)
Butyl lactate is used as a solvent for nitrocellulose, ethyl cellulose, oils, dyes,
natural gums, many synthetic polymers, lacquers, varnishes, inks, stencil pastes,
anti skinning agent, dry-cleaning fluids, and adhesives. It is also used in cosmetic
products up to a maximum concentration of 0.03 % (10). It has been approved by
the US FDA for food use (3).
Ethylhexyl lactate has in recent years been used as degreaser (8).
5Myristyl lactate functions as a skin-conditioning agent - emollient in a variety of
cosmetic product categories. The concentrations are reported to range from >1.5 %
in makeup and skin-care preparations to 15 % in eye shadow formulations. In the
US myristyl lactate was (1984) used in 292 cosmetic formulations at a concentration
of £  50 %, usually in the range of 5 - 10 % (10).
Cetyl lactate is used as a non-ionic emollient and to improve the feel and texture
of pharmaceutical preparations (22). Cetyl lactate functions as a skin-conditioning
agent. In 1984 it was used in the US in 224 cosmetic formulations at a concen-
tration of £  25 %, usually in the range of 1 - 5 % (10).
5. Occupational Exposure
According to the Documentation of the TLVs (1), prolonged exposures to n-butyl
lactate at concentrations of 7 to 11 ppm resulted in headache and irritation of the
pharyngeal and laryngeal mucosa in all workers. The information is based on a
personal written communication to the TLV Committee.
In a Swedish company, the average air concentration of ethyl lactate around
degreasing of metal products was found to be 0.6 ppm. Around some operations
near a cleaning tunnel the concentration was considerably higher and peaks close to
10 ppm were registered. The 8 h average, however, was calculated to be 4.2 ppm
(8).
6. Sampling and Analysis of Substance at Work Place
For the two lactate esters, n-butyl lactate and ethyl lactate, the US OSHA has given
information on sampling and analysis. In both cases charcoal tubes (100/50 mg
sections, 20/40 mesh) are used for sampling. As solvent methylene chloride:
methanol (95:5) is preferred. Maximal sampling volume is 10 L with a maximum
flow of 0.2 L/min. For analysis gas chromatography (GC/FID) is used. According
to the OSHA the method is partially validated, but no data are given (18).
The concentration of ethyl lactate in air can also be evaluated by using FTIR
(Fourier-Transform Infra Red) spectrophotometry. By FTIR absorbance over a
large portion of the IR-spectrum is registered. Obtained spectra are chequed against
a library of absorption spectra for different substances. The instrument uses a cuvett
of 2.3 L volume and a fixed beam of 10 m (8).
67. Toxicokinetics
7.1. Uptake and distribution
There are no quantitative data on respiratory uptake of lactate esters. From animal
inhalation studies it can be concluded that the esters, or the hydrolysis products, are
taken up.
When a preparation containing ethyl [14C] lactate was applied to the skin of rats
for up to 24 hours, most of the radioactivity was traced in sebaceous glands, but it
appeared also in hair follicles, epidermis and dermis (19). Ethyl lactate was detected
in portal blood of rats following intragastric instillation, indicating partial absorption
before hydrolysis.
7.2. Biotransformation
Enzymatic hydrolysis of lactate esters to lactic acid and alcohol  has been reported
after oral administration as well as after skin application (7). The in vitro hydrolysis
of various lactate esters in the rat nasal epithelium is demonstrated to be rapid (9).
The in vitro and in vivo hydrolysis of ethyl lactate in the gastrointestinal tract of rats
has also been demonstrated.
In an in vitro study, rat plasma hydrolyzed 80 % of ethyl lactate in 60 min at
room temperature (9). In various rat tissue homogenates of the nasal epithelium,
liver and skin the Km values of ethyl lactate was similar (0.06-0.36 mM). The value
in cecum was intermediate while blood and small intestinal mucosa showed high Km
values or first order kinetics (9).
The hydrolysis of 2-ethylhexyl lactate has been investigated in rat organs. The
most rapid hydrolysis was observed in the intestinal mucosa followed by cecum,
blood, and skin. The kinetic values for the blood were equal to the values for the
nasal tissues (9).
Lactic acid/lactate ion is an endogenous metabolite. Effects of the hydrolysis
products of lactate esters are shortly discussed in chapter 9.
7.3. Tissue clearance and elimination
There are no quantitative data of clearance and elimination of lactate esters. Due to
the relatively rapid hydrolysis the elimination pathways are the same as for lactic
acid and alcohols, respectively.
8. Methods of Biological Monitoring
Today, there is no suitable method described for biological monitoring of lactate
esters.
79. Mechanisms of Toxicity
Lactic acid, the hydrolysis or metabolic product of all lactate esters, is a normal and
natural metabolite in humans. Lactic acid toxicity is mainly related to its acidity.
Concentrated lactic acid is a potential eye and skin irritant. The oral LD50 is
3.73 g/kg body weight in rats and 1.81 g/kg in guinea pigs.
Alcohols, the other hydrolysis product of lactate esters, have generally a low
acute toxicity but may produce mild eye and skin irritation at high concentrations.
Specific alcohols have been reported to cause certain effects. Large doses of methyl
alcohol can produce blindness and death. Ethyl alcohol is a developmental hazard in
humans. Several 2-ethylhexyl compounds have been reported to be carcinogenic in
animals, probably due to peroxisome proliferation (12). A toxicological evaluation
of 2-ethyl-1-hexanol did not indicate genotoxicity nor carcinogenicity (11). An oral
gavage study showed that ethylhexanol was not carcinogenic in rats but a weak
trend of hepatocellular carcinomas was noted in high-dose mice (5).
10. Effects in Animals and in vitro Studies
10.1. Irritation and sensitisation
Irritation
Many lactate esters are irritating to the eye and skin, probably due to hydrolysis
which produces lactic acid (9).
Methyl lactate has been classed as non-irritant to the eyes of guinea pigs (20).
Besides in vivo eye irritation tests also an in vitro chicken enucleated eye test was
conducted. Tests of ocular irritation have demonstrated that ethyl lactate in vivo
causes moderate to severe irritation. Propyl lactate was shown to severely irritate the
eye in vivo and had an irritative, probably corrosive, effect in vitro. Also butyl and
amyl lactate caused severe irritation in the eye. Lauryl lactate caused in vivo minimal
to mild irritation and in vitro minimal to moderate irritation. Myristyl lactate caused
in vivo no to mild irritation and in vitro minimal to mild irritation and cetyl lactate
caused in vivo no to severe irritation and in vitro minimal to mild irritation. For the
in vivo studies albino rabbits were used and in the in vitro studies the Eyetex assay
protocol was used (9, 10, 13).
No skin irritation was observed when the primary potential of a formulation
containing 50 % ethyl lactate was evaluated in single insult patch test using rabbits
(10). No irritation was reported when ethyl lactate was applied under occlusive
gauze pads, 2 cm2, to the shaved abdominal skin of rabbits, but intradermal
injection of 0.1 mL ethyl lactate into the shaved abdominal skin of guinea pigs
produced severe irritation (13).
Application of butyl lactate to 10 rabbits produced moderate and marked erythema
in eight and two animals, respectively, and slight and moderate edema in one and
nine animals, respectively. The lactate was assumed to be applied undiluted under
occlusive patches to intact and abraded skin for 24 hours (10).
8No skin irritation was observed when propyl lactate or isopropyl lactate were
tested (9).
Mild to minimal irritation was observed when the primary potential of two
cosmetic formulations containing lauryl lactate was evaluated in single insult
occlusive patch tests using rabbits. The same results were obtained when formu-
lations containing myristyl lactate or cetyl lactate were tested. The maximum
concentration of the lactate esters in the formulations was 12 % (10).
As a measure of cytotoxicity rabbit and human skin cell proliferation were
determined in skin culture. The data indicate that human skin cells are less sensitive
than rabbit skin cells. Furthermore, higher molecular weight esters seem to be more
toxic than those with lower molecular weight (9).
In a sensory irritation study ethyl and butyl lactates were used in mice and rats.
The RD50 values (50 % decrease in respiratory rate) for both esters were approxi-
mately 750 - 800 mg/m3 (9).
Sensitisation
The allergic contact sensitisation potential of lauryl lactate was evaluated in a
modified Magnusson-Kligman maximization test using 10 female guinea pigs. The
induction phase consisted of intradermal injections of 0.05 mL of 5 % lauryl lactate
in propylene glycol, 50 % aq. Freund's adjuvant (FCA), and 5 % lauryl lactate and
50 % aq. FCA. One week after induction, a topical booster of 50 % lauryl lactate in
petrolatum was applied to the induction site. Two weeks after the booster, occlusive
patches of 5 and 25 % lauryl lactate in petrolatum were used for the challenge. At
72 hours after challenge, none of the animals had reacted to the 5 % concentration.
With the 25 % challenge 30 % of the animals reacted (10).
The allergic contact sensitisation potential of a formulation containing 0.75 %
cetyl lactate was evaluated in the same test system as above using 10 female guinea
pigs. The induction phase was as above with 50 % of the formulation. One week
after the induction, a topical booster of 100 % of the test formulation in petrolatum
was applied. Two weeks after the booster, occlusive patches of 50 and 100 % of
the test material in petrolatum were used for the challenge. The sites were scored 48
and 72 hours after patch application. None of the animals reacted and a formulation
containing 0.75 % cetyl lactate was not considered a sensitizer (10).
These high molecular lactate esters are probably not sensitizers.
10.2. Effects of single exposure
In acute inhalation studies using rats exposed nose-only for 4 hours, the target
concentration was 5000 mg/m3. Clinical observations, mortality, body weights and
gross pathological changes were recorded during a 14 day observation period.
Clinical signs indicated acute irritation but no mortality was noted. The 4 h LC50
was for all tested lactate esters above 2400 mg/m3. The esters tested were methyl-,
ethyl-, butyl-, isobutyl-, and isoamyl-ester (9).
Oral LD50 has been determined in rats for several lactate esters. No mortality was
seen for any lactate ester at 2000 mg/kg body weight, the highest concentration
9tested (9). The oral LD50 for rats of a nail enamel corrector formulation containing
50 % ethyl lactate was determined in studies where fasted female rats were given 5,
10 or 15 g/kg body weight. There were no deaths at 5 g/kg, 4 deaths of 5 rats at 10
g/kg and all animals in the highest dose group died. The LD50 was calculated to be
8200 mg/kg body weight (10).
Using 10 rats the oral LD50 of ethyl lactate was >5000 mg/kg body weight. One
animal died during the 14-day observation period (10). In another study the LD50 of
ethyl lactate for white mice was 2.5 mL/kg (»  2.6 g/kg bw) and the LD100 was
4.0 mL/kg ( »  4.1 g/kg bw). The minimum toxic dose (producing hypnotic signs in
one of four mice) was 0.4 mL/kg ( »  0.4 g/kg bw) and the maximum non toxic dose
was 0.2 mL/kg ( »  0.2 g/kg bw) (13).
For toxicological experiments esters were injected intramuscularly into the upper
part of the leg of guinea pigs. The animals were observed continuously for several
hours and then examined daily for a week. Lactate esters used in this unusual type
of study were ethyl lactate and isopropyl lactate. For ethyl lactate a given dose of
2.5 mL/kg ( »  2.6 mg/kg bw) was lethal. At 1.0 mL/kg ( »  1.0 g/kg bw) the animals
had labored respiration and were dyspneic. For isopropyl lactate the lethal dose was
the same 2.5 mL/kg (»  2.5 g/kg bw). At the given dose of 1.25 mL/kg (»  1.25 g/kg
bw) the animals demonstrated lack of muscular control (14).
When 5 g/kg body weight of butyl lactate was given orally to 10 rabbits there
were no deaths, demonstrating that the LD50 >5000 mg/kg body weight (10).
The acute oral toxicity of a number of freshener formulations containing lauryl
lactate has been evaluated. In all cases was the LD50 >5000 mg/kg body weight.
Similarly the rat oral LD50 for formulations containing myristyl lactate was
>10000 mg/kg body weight. The same results were obtained with formulations
containing cetyl lactate (10).
Acute dermal toxicity has been tested in rats at 2 g/kg body weight. Slight dermal
encrustatation was noted in one third of the rats on day 3. No mortality or gross
treatment-related necropsy observations were observed (9).
There were no deaths during a 7-day observation period in 10 rabbits when
5 g/kg body weight of ethyl lactate was applied to the skin. Thus, the dermal
LD50was >5000 mg/kg body weight. The maximum tolerated dose applied to mouse
skin was 250 mg/kg body weight (10).
When 5 g/kg body weight of butyl lactate was applied to the skin of 10 rabbits
there were no deaths. The dermal LD50 was, thus, >5000 mg/kg body weight (10).
The estimated average lethal dose for the female rat following i.p. injection of
methyl lactate was >2000 mg/kg body weight. Observations included narcosis,
respiratory distress and peritoneal adhesions. The estimated non toxic dose and
estimated maximum dose without gross lesions at necropsy was 500 mg/kg body
weight (20).
Approximately 1000 mg/kg body weight was the estimated average lethal dose
for the female rat following i.p. injection of ethyl lactate. The estimated maximum
non toxic dose was 750 mg/kg body weight and the estimated maximum dose
without gross lesions at necropsy was >500 mg/kg body weight (20).
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The subcutaneous LD50 of ethyl acetate for white mice was 2.5 mL/kg body
weight ( »  2.6 g/kg bw), and the i.v. LD50 was 0.6 mL/kg body weight ( »  0.6 g/kg
bw). The maximum non toxic dose after s.c. administration was 0.8 mL/kg
( »  0.8 g/kg bw) and after i.v. administration 0.2 mL/kg body weight (»  0.2 g/kg
bw) (13).
10.3. Effects of short-term exposure
Inhalation studies have been conducted in rats, where groups of males and females
were exposed during 28 days, 5 days/week, 6 h per day. Two studies were
conducted on ethyl lactate. In one of the studies the exposure levels were 0, 150,
600 or 2500 mg/m3 and in the other 0, 25, 75 or 200 mg/m3. No treatment-related
clinical signs, changes in body or organ weights (e.g. increased adrenal and testes
weights), hematology or biochemistry were observed in doses up to 600 mg/m3. In
the highest dose group decreased body weight gain, decreased absolute liver
weight, decreased food consumption and increased blood glucose (males) were
significantly different from the control.  At the two highest concentrations
degenerative changes of the nasal olfactory epithelium were seen, and in addition
hyperplasia of the goblet cells (9). See also Table 2 in chapter 12.
In a similar study isobutyl lactate was tested at 0, 100, 200, 400 or 800 mg/m3.
Hyperplasia of the nasal respiratory  epithelium was noted in all animals at 800
mg/m3 and most animals at 400 mg/m3. At the highest dose level disarrangement of
the nasal olfactory epithelium was noted in 60 % of the animals. No other treatment-
related changes were reported (9). See also Table 2 in chapter 12.
When n-butyl lactate was tested at 0, 75, 200 or 600 mg/m3 in a similar way,
only slight focal hyperplasia of the nasal epithelium was seen in the highest dose
group. No other treatment-related effects were reported (9). See also Table 2 in
chapter 12.
In a 28-day study an aerosol of 2-ethylhexyl lactate was used. Groups of rats of
both sexes were exposed 5 days/week, 6 h per day to 0, 75, 200, 600 or
1800 mg/m3. Histopathological changes of the respiratory tract were observed in all
treated groups. In the lowest exposure group changes were seen only in the nasal
cavity, but in all other treated groups also larynx, trachea and lungs showed
changes. In the highest exposure group  a doubling of peroxisome proliferation was
observed. In a follow-up, comparative study groups of male rats were exposed to
an aerosol or vapors of 2-ethylhexyl lactate. The concentration was 75 mg/m3 and
the rats were exposed nose-only for 4 weeks, 5 days/week, 6 h per day. The effects
of aerosol exposure were similar to the previous study, slight focal hyperplasia of
the nasal respiratory epithelium. The response was less in the vapour exposed
animals (9). See also Table 2 in chapter 12.
Groups of 20 Sprague-Dawley rats, 10 per sex, were dosed orally with 0, 0.5,
2.5 or 5.0 mg/kg body weight myristyl lactate 5 days/week for 13 weeks. All
animals survived. Body weight gain was significantly decreased in males in the
high dose group. Statistically significant changes were observed in some clinical
chemistry values especially in the high dose group. At necropsy, three males of the
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high dose group, one of the mid-dose group and three females of the high dose
group had enlarged livers. Liver weight was significantly increased in males and
females of the two highest dose groups. Dose-related effects were also seen in the
gastrointestinal tract, including enlargement or thickening of the walls of the
stomach and duodenum. At microscopic examination of selected tissues, alterations
found included a dose-related diffuse mucosal hyperplasia in the duodenum of
treated animals, inflammatory and/or proliferative lesions in the non-glandular
stomach of several mid- and high-dose rats, and hepatic changes, primarily Kupffer
cell hypertrophy and a slight disorganization of hepatic cords in some areas, in four
males and three females of the high-dose group. The researchers concluded that
"because of the exaggerated conditions used in the study, myristyl lactate is
considered safe for use in oral area cosmetic products" (10).
A group of 15 female rats were used to determine the toxicity of a lipstick
formulation containing 7.5 % cetyl lactate. The animals were dosed orally with
1000 mg/kg of the formulation in corn oil once daily 5 days/week for 6 weeks. The
control animals received corn oil. The serum alkaline phosphatase values were
significantly increased in dosed animals. Also the kidney weights were significantly
greater than in controls. None of these differences were considered toxicologically
significant. All other measurements were similar between the groups and no micro-
scopic lesions were found (10).
A group of 15 male rats were used to determine the dermal toxicity of an after-
shave moisturizer containing 0.75 % cetyl lactate. The formulation at a dose of 1870
mg/kg body weight was applied by gentle inunction to a shaved dorsal site once
daily 5 days/week for 13 weeks for a total of 68 doses. No statistically toxicologi-
cally significant differences between dosed animals and controls were observed.
Similarly, the dermal toxicity of a moisturizing cream formulation containing 1 %
cetyl lactate has been tested. The total dose of the formulation was 920 mg/kg body
weight given as 67 applications. No toxicologically significant differences between
dosed animals and controls were found (10).
Ethyl lactate was reportedly a good energy source and enhanced growth in a
group of 8 male weanling rats fed a diet containing 5 % of this ester (approximately
equivalent to 5 g/kg bw) over a period of 12 days. One of 8 animals died during the
course of the experiment. There was no indication of the cause of death. No adverse
effects were observed in the surviving animals (23, 24).
10.4. Effects of long-term exposure and carcinogenicity
No data available.
10.5. Mutagenicity and genotoxicity
Ethyl lactate has been tested for mutagenicity in the Ames test using the strains TA
98, 100, 1535, 1537 and 1538 with and without metabolic activation. No muta-
genic activity was observed in any tester strain. Lack of mutagenic activity has also
been demonstrated for 2-ethylhexyl lactate in Salmonella or E. coli bacteria (9).
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10.6. Reproductive and developmental toxicity
Ethyl lactate was applied percutaneously on the back of groups of pregnant rats on
days 6 to 15 of gestation. Applied doses were 0, 517, 1551 or 3619 mg/kg body
weight. Slight erythema and desquamation was observed in treated animals at the
application site. No other clinical signs or necropsy observations were noted. No
effects were observed on the development (9).
Pregnant rats were exposed to an aerosol of 2-ethylhexyl lactate. Twelve rats per
group were exposed for 6 hours per day from day 6 to 15 of gestation for 0, 200 or
600 mg/m3. There were no signs of maternal toxicity. The only treatment-related
effect was a significant reduced feed consumption at 600 mg/m3 and a slight
decrease in the low-dose group. Delayed ossification of the frontalis, metatarsals,
and hind limb phalanges was observed in both treatment groups. These effects were
regarded as related to stress rather than the manifestation of toxicity by the ester
itself (9).
10.7. Immunotoxicity
No data available.
11. Observations in Man
11.1. Effects by contact and systemic distribution
The lack of data suggest that lactate esters in general are not skin sensitizers.
However, a single case of skin sensitisation has been reported where ethyl lactate
was used as a component in an acne medicine (9). This is probably the same case as
that of Marot et al who reported a case of allergic contact dermatitis to ethyl lactate.
A gel containing 10 % ethyl lactate as the active ingredient gave acute rash on the
cheeks, diagnosed as allergic contact dermatitis. Patch tests performed six weeks
later, gave a positive response to the gel and to 1 % ethyl lactate in petrolatum.
Control patients were all negative (16).
A 44-year-old woman had applied a moisturizing cream daily to her face for at
least 5 years. For the past three months, itching had occurred a few hours after
application and for the past 2 weeks there had been dermatitis on her face. She was
patch tested with the ingredients of the cream, including myristyl lactate 0.5 %
/maleated soybean oil 1.5 % and myristyl lactate 0.5 %. The patient showed a
positive reaction to myristyl lactate/maleated soybean oil. Myristyl lactate gave a
negative response. No reactions were seen in 20 control persons. The authors
suggest that maleated soybean oil was the cause of this allergic reaction (21).
11.2. Effects of repeated exposure on organ systems
An unpublished report to the ACGIH TLV-committee states that prolonged
exposure to n-butyl lactate at concentrations of about 7 ppm (»  43 mg/m3) with
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short peak exposures of 11 ppm ( »  67 mg/m3) resulted in headache and irritation of
the pharyngeal and laryngeal mucosa with coughing in all workers. Some workers
complained of sleepiness and headache after work. Occasional nausea and vomiting
were experienced. Complaints of irritation of the conjunctiva were not confirmed by
examination. Blood and urine routine clinical analyses were normal. Some of the
symptoms (headache, coughing, pharyngitis) were related to an air concentration of
4 ppm (»  24 mg/m3) measured by personal monitoring. No signs of symptoms
were seen when the concentration was below 1.4 ppm (»  8 mg/m3) (1).
In a subsequent study, unpublished, using improved analytic methods it was
stated that levels of 7 ppm (»  43 mg/m3) n-butyl lactate did produce a readily
discernible odor, but was not found to be injurious or objectionable (1).
11.3. Genotoxic effects
No data available.
11.4. Carcinogenic effects
No data available.
11.5. Reproductive and developmental effects
No data available.
12. Dose-Effect and Dose-Response Relationships
For many of the lactate esters toxicological data are very sparse and it is not possible
to describe a dose-effect and/or a dose-response relationship.
There are practically no human data which can be used for evaluation of dose-
effect and dose-response relationships.
Data from animal inhalation studies are summarized in Table 2.
The RD50 for ethyl lactate as well as for n-butyl lactate has been estimated to be
750-800 mg/m3 both for rats and mice.
In studies where myristyl lactate was given orally to rats, liver weights were
significantly increased at a daily dose of 2.5 mg/kg body weight or above. The
NOAEL for oral exposure to myristyl lactate was found to be 0.5 mg/kg body
weight.
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Table 2. Effects of some lactate esters on rats exposed 28 days, 5 days/week, 6
hours/day. (From ref 9)
Lactate Exposure Effect
mg/m3 ppm
ethyl 2500 500 Significantly decreased body weight gain
(vapor) Significantly decreased absolute liver weight
Significantly decreased food consumption
Significantly increased blood glucose
Degenerative changes of nasal olfactory epithelium
Hyperplasia of goblet cells
600 120 Degenerative changes of nasal olfactory epithelium
Hyperplasia of goblet cells
200 40 NOAEL
n-butyl 600 99 Slight focal hyperplasia of nasal epithelium
(vapor) 200 33 NOAEL
isobutyl
(vapor)
800 132 Disarrangements of nasal olfactory epithelium
Hyperplasia of nasal respiratory epithelium
400 66 Hyperplasia of nasal respiratory epithelium
200 33 NOAEL
2-ethylhexyl
(aerosol)
1800 216 Histopathological changes in nose, larynx, trachea, lungs
Doubling of peroxisome proliferation
600 72 Histopathological changes in respiratory passages
200 24 Histopathological changes in respiratory passages
75 9 Histopathological changes in nasal cavity
LOAEL
(vapor) 75 9 Focal hyperplasia of nasal respiratory epithelium
LOAEL
13. Previous Evaluations by (Inter)national Bodies
ACGIH in their documentation for the TLV© of n-butyl lactate recommends a TWA
occupational exposure limit of 5 ppm as levels below 7 ppm were not injurious to
workers. The level of 5 ppm is recommended to prevent irritation of mucosa and
headache. The recommendation is mainly based on unpublished written
communications to the TLV committee (1).
The Swedish Criteria Group in 1995 conclude in their consensus report on
"Lactates" that available data are too sparse to allow a dose-response or dose-effect
relationship to be identified. The little amount of data indicate that the critical effect
of occupational exposure to n-butyl lactate and ethyl lactate is irritation of mucous
membranes. For other lactates there are no data indicating a critical effect (15).
Based on given scientific and other information an OEL of 5 ppm was adopted by
the Swedish National Board of Occupational Safety and Health for the two lactates
(17).
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14. Evaluation of Human Health Risks
14.1 Groups at extra risk
No special occupational or constitutional groups seem to be at extra risk by
occupational exposure to lactate esters.
14.2 Scientific basis for an occupational exposure limit
The lactate esters are not very toxic. In animal inhalation studies the NOAEL for
ethyl-, n-butyl- and isobutyl lactate is 200 mg/m3. Of the lactate esters tested in rats
only 2-ethylhexyl gave an effect on the nose at a lower dose and a LOAEL for this
ester is 75 mg/m3. Also the 4 h LC50 value for all esters tested is above 2400 mg/m3
and the oral LD50 values have been more than 2 g/kg body weight.
In studies where myristyl lactate was given orally to rats, liver weights were
significantly increased at a daily dose of 2.5 mg/kg body weight or above. The
NOAEL for oral exposure to myristyl lactate was found to be 0.5 mg/kg body
weight.
The similarities in toxicity response for low molecular weight lactate esters
suggest that the acidity of lactic acid is most likely the cause of toxicity. For high
molecular weight lactate esters also the exposure to aerosol must be of concern.
In humans only one study is reported which implies effects. The study reports
effects after exposure to n-butyl lactate at levels above 7 ppm (»  43 mg/m3), but it
does not give any details and has not been published.
Based on the limited amount of data it is concluded that the critical effect for
occupational exposure to lactate esters is irritation of the mucous membranes in nose
and throat. The effect is probably due to lactic acid.
15. Research Needs
The lack of studies for several lactate esters implies that studies should be per-
formed, although most of the lactate esters seem not to be very toxic.
No carcinogenesis studies have been reported. Such a study might be of interest
for 2-ethylhexyl lactate as an increase in peroxisome proliferation has been seen in
rats exposed for 28 days. On the other hand the mechanism of carcinogenicity from
peroxisome proliferators is probably not of interest in the human situation.
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16. Summary
Lundberg P. Lactate esters. DECOS and SCG Basis for an Occupational Standard.
Arbete och Hälsa 1999;9:1-21.
Lactate esters (esters of lactic acid) are used as food additives, in pharmaceuticals
and cosmetics and are currently finding new uses as solvents. Lactate esters are
hydrolyzed to lactic acid and alcohol. Lactic acid is a normal metabolite in humans.
The toxicity of lactate esters is most likely due to the acidity of lactic acid. Based on
animal data the critical effect of occupational exposure to lactate esters is irritation of
the mucous membranes in nose and throat. Only unpublished studies in humans are
available.
Keywords: Hazard assessment, Irritation, Lactate esters, Lactic acid, Occupational
Exposure Limit, Toxicity.
17. Summary in Swedish
Lundberg P. Lactate esters. DECOS and SCG Basis for an Occupational Standard.
Arbete och Hälsa 1999;9:1-21.
Laktatestrar (mjölksyreestrar) används som additiv till matvaror, i farmaceutiska och
kosmetiska produkter och på senare tid som lösningsmedel. Estrarna hydrolyseras
till mjölksyra och alkohol. Mjölksyra är en naturlig metabolit i människokroppen.
Laktatestrarnas toxicitet beror troligtvis på mjölksyrans surhetsgrad. Baserat på
djurdata är den kritiska effekten vid yrkesmässig exponering för laktatestrar
irritation av slemhinnor i näsa och svalg. För människa finns endast opublicerade
studier.
Nyckelord:  Hygieniskt gränsvärde, Irritation, Laktatestrar, Mjölksyra,
Riskbedömning, Toxicitet.
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19. Data Bases Used in Search for Literature
In the search for literature the following data bases were used:
- NIOSHTIC
- Cancerline
- Chemical Abstracts
- Medline
- Toxline
- RTECS
The latest search was performed in October, 1998, at the library of the Swedish
National Institute for Working Life. In order not to miss any references the only
search-words used were the CAS numbers and the names of the substances.
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Appendix
Physical and chemical properties for some of those lactate esters where data on
effects are scarce or missing.
Propyl lactate
Boiling point 170 ˚C
Flash point 69 ˚C
Density 1.005 g/ml (20 ˚C)
Vapor pressure 0.11 kPa (20 ˚C)
Partition coefficient (log Poctanol/water) 0.51
Conversion factor (20 oC; 101.3 kPa) 1 ppm = 5.5 mg/m3
1 mg/m3 = 0.18 ppm
Propyl lactate is miscible with water at room temperature (9).
sec-Butyl lactate
Boiling point 174 ˚C
Flash point 70 ˚C
Density 0.973 g/ml (20 ˚C)
Vapor pressure 0.11 kPa (20˚C)
Partition coefficient (log Poctanol/water) 1.01
Conversion factor (20 oC; 101.3 kPa) 1 ppm = 6.1 mg/m3
1 mg/m3 = 0.165 ppm
Sec-butyl lactate is soluble in water; 14.4 g/100 ml at 20 ˚C (9).
Isoamyl lactate
Boiling point 202 ˚C
Flash point 85 ˚C
Density 0.961 g/ml (20˚C)
Vapor pressure 0.02 kPa (20˚C)
Partition coefficient (log Poctanol/water) 1.62
Conversion factor (20 oC; 101.3 kPa) 1 ppm = 6.8 mg/m3
1 mg/m3 = 0.15 ppm
Isoamyl lactate is slightly soluble in water; 0.3 g/100 ml (9).
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Amyl lactate
Boiling point 207 ˚C
Flash point 87 ˚C
Density 0.964 g/ml (20˚C)
Vapor pressure 0.01 kPa (20 ˚C)
Partition coefficient (log Poctanol/water) 1.62
Conversion factor (20 oC; 101.3 kPa) 1 ppm = 6.8 mg/m3
1 mg/m3 = 0.15 ppm
Amyl lactate is slightly soluble in water at room temperature; 0.3 g/100 ml (9).
n-Octyl lactate
Boiling point 258 ˚C
Flash point 126 ˚C
Density 0.943 g/ml (20 ˚C)
Vapor pressure 0.0001 kPa (20 ˚C)
Partition coefficient (log Poctanol/water) 3.17
Conversion factor (20 oC; 101.3 kPa) 1 ppm = 8.4 mg/m3
1 mg/m3 = 0.12 ppm
The solubility of n-octyl lactate in water is 30 mg/100 ml (9).
n-Decyl lactate
Boiling point 283 ˚C
Flash point 136 ˚C
Density 0.942 g/ml (20 ˚C)
Vapor pressure 0.0002 kPa (20 ˚C)
Partition coefficient (log Poctanol/water) 4.21
Conversion factor (20 oC; 101.3 kPa) 1 ppm = 9.4 mg/m3
1 mg/m3 = 0.106 ppm
The solubility of n-decyl lactate in water is 20 mg/100 ml (9).
